Heritage Pharma Avet has secured FDA approval for its Abbreviated New Drug Application (ANDA 076228), a development expected to generate new revenue streams and solidify the company’s market position as it prepares for the commercial launch.
Heritage Pharma Avet has secured FDA approval for its Abbreviated New Drug Application (ANDA 076228), a development expected to generate new revenue streams and solidify the company’s market position as it prepares for the commercial launch.